Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Medical General » Advances in Medicine and Biology. Volume 77 Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
UK National Security Strategy and Decision Planning
$110.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to IL-7 in Rheumatoid Arthritis: Pathogenesis, Biomarker and Rationale for Anti-IL-7 Therapy (pp. 31-64)
Tell A Friend
 
Tell someone you know about this product.
IL-7 in Rheumatoid Arthritis: Pathogenesis, Biomarker and Rationale for Anti-IL-7 Therapy (pp. 31-64) $0.00
Authors:  (Frederique Ponchel, Agata Burska, Effie Myrthianou, George Goulielmos, Leeds Institute of Rheumatic and Musculoskeletal Medicine & Leeds Musculoskeletal Biomedical Research Unit, The University of Leeds, Leeds, UK, and others)
Abstract:
Rheumatoid arthritis (RA) is a chronic disease primarily affecting the joints and
producing marked inflammatory changes in the synovial membrane and adjacent
structures. Although any joint can be affected the disease normally affects the hands, feet,
knees and wrists. Disease activity and the rate of progression to involve new joints are
variable. The pain and disability associated represent a real burden both for the patients
and society and the disease is also associated with premature mortality [1, 2].
There is currently no cure for RA. Historically, treatments which deplete T-cells led
to reduction of symptoms supporting the notion of a T cell mediated disease. Today, the
pathology is thought to be the product of a series of complex cellular interactions where
synovial T-cells orchestrate disease through their interaction with fibroblasts, B-cells,
dendritic cells, and macrophages. Modern treatment options include the use of
“biological” drugs, which block cytokines such as TNF alpha, IL-1, IL-6, limit costimulation
between B and T-cells or deplete B-cells. Although their use bring great
benefit, a wide range of adverse events have been reported (including infections, cancer,
vasculitis, lupus-like and multiple sclerosis, liver disease, hematologic abnormalities
(such as aplastic anemia, lymphoma) and aseptic meningitis). In addition resistance to
these agents or loss of response, relapse on cessation of treatment, side effects occurs in
more than 40% of patients. The cost of these therapies is also major pitfall.
The complex cellular interactions in the synovium between stromal cells, T-cells and
their subsequent effect on B-cells, macrophages and endothelial cells provide a large
panel of alternative targets, both cellular and molecular, for therapeutic intervention in
RA. Inhibiting cytokines signalling has proven successful and we (and others)
hypothesise that IL-7 may be an appropriate therapeutic target in RA as well as in several
other autoimmune diseases. The main rational for targeting IL-7 is that it is (i) over
expressed specifically at the disease site, however only in active disease, (ii) not capable
of exiting the joint (due to its retention and presentation by extra-cellular matrix) (iii)
produced by local resident cells with no mobility (i.e. fibroblasts). In addition, low levels
of circulating IL-7 in RA patients suggest that efficient inhibition of IL-7 signalling may
only take place in the joint. The role of IL-7 in the disease itself is slowly being dissected
and will be reviewed to support this statement. 


Available Options:
Version:

  Open Access item.
  Click below PDF icon for free download.

  

This is an Open Access item. Click above PDF icon for free download.
Special Focus Titles
01.The Bronze Mask: Protagonists of English Literature
02.Biotechnological Applications of Seaweeds
03.The Lonely Ape that Told Himself Stories: The Necessity of Stories for Human Survival
04.Different Aspects on Chemotherapy of Trypanosomatids
05.Pediatric Surgery Handbook for Residents and Medical Students
06.Fighting for a Gender[ed] Identity: An Ethnographic Examination of White Collar Boxers
07.Blood Viscosity: Its Role in Cardiovascular Pathophysiology and Hematology
08.Neonatal and Perinatal Mortality: Global Challenges, Risk Factors and Interventions
09.Trichotillomania (Hair Pulling Disorder): Clinical Characteristics, Psychological Interventions and Emotional Effects
10.Thyroid Nodules and Cancer: A Simplified Case Oriented Approach
11.Biliary Diseases with Pancreatic Counterparts: A New Disease Concept
12.SAFETY & PERFORMANCE
Total Respect Management (TR3M): A Novel Approach to Achieve Safety and Performance Proactively in Any Organisation

Nova Science Publishers
© Copyright 2004 - 2017

IL-7 in Rheumatoid Arthritis: Pathogenesis, Biomarker and Rationale for Anti-IL-7 Therapy (pp. 31-64)